INPADS

InPads is a biotechnology company focused on the development of advanced transdermal drug delivery systems using its proprietary Intelligent Nanoparticle Delivery System (INPADS) platform. The technology utilizes ionic liquids and nanoparticles to overcome the skin's natural barrier, enabling the needle-free delivery of a wide range of therapeutics, including small molecules, peptides, and proteins. By enhancing the penetration and localized concentration of drugs, InPads aims to improve treatment outcomes for dermatological conditions such as psoriasis and atopic dermatitis while minimizing systemic side effects. The company's approach represents a significant shift in topical therapy, offering a more effective and patient-friendly alternative to traditional injections and oral medications.